ITI Pharma and Healthcare Fund
NAV : ₹ 15.639 as of 17 December, 2025
Overview
₹ 230.85 Cr
Fund size
₹ 500
Min SIP
₹ 5000
Lumpsum
18 October 2021
Launch date
Growth
Fund plan
Regular
Scheme type
2
Rating by Value Research
Return Calculator
₹ 5,000
Over the past
Total Investment of ₹1,80,000
Monthly SIP of ₹5,000 would have become ₹2,43,228 in 3 years with a gain of ₹63,228 (+26.00%)
Disclaimer: Past performance is not an indicator of future returns
Top Holdings
Sun Pharmaceutical Industries Ltd. | 12.73% |
Divi's Laboratories Ltd. | 8.75% |
Apollo Hospitals Enterprise Ltd. | 6.12% |
Max Healthcare Institute Ltd. | 6.08% |
Torrent Pharmaceuticals Ltd. | 4.26% |
Equity Holding(s) Distribution
Other Scheme Info
Expense Ratio
Inclusive of GST
2.35%
Stamp Duty
0.005%
Exit Load
Exit load of 0.50%, if redeemed within 3 months.
0
View Scheme Document
Peer Analysis
View more
Compare Funds
Compare with other funds
ITI Pharma and Healthcare Fund Managers
List of ITI Mutual Fund's top performing schemes
23.69% | |
22.97% | |
18.97% | |
18.45% | |
17.19% | |
12.86% | |
12.72% | |
Fund House
ITI Mutual Fund
Total AUM: 11336.09Cr
Founded in 2018, ITI Mutual Fund is dedicated to offering superior investment solutions for long-term wealth creation among investors. As part of the ITI Group of Companies, a growing conglomerate providing diverse financial services such as equity research (for both retail and institutional clients), equity broking (for both retail and institutional clients), investment banking, asset-based lending, and alternative investment funds, the AMC has positioned itself as a comprehensive financial service provider. As of December 2023, the AMC manages assets amounting to Rs. 5355 crores.
Learn more about ITI Mutual Fund
Kotak Securities Limited: AMFI-registered Mutual Fund Distributor
FAQ for ITI Pharma and Healthcare Fund
Start SIP with just Rs.100
Start SIP with just Rs.100